Publikacje naukowe  z wykorzystaniem infrastruktury CDT-CARD

Uncovering Urinary Proteome Differences in Very Preterm Infants with and without Preterm Brain Injury.

Zasada M, Suski M, Olszewska M, Kowalik A, Łapińska N, Pogoda W, Kwinta P.

J Proteome Res. 2025 Sep 9. doi: 10.1021/acs.jproteome.5c00392. Online ahead of print.

PMID: 40924950, https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00392

Comparative effectiveness of moderate treadmill training and venlafaxine treatment on long-lasting brain changes induced by prenatal dexamethasone exposure.

Głombik K, Kukla-Bartoszek M, Suski M, Curzytek K, Grygier B, Basta-Kaim A.

Neuropharmacology. 2025 Nov 15;279:110604. doi: 10.1016/j.neuropharm.2025.110604. Epub 2025 Jul 28.

PMID: 40738385, https://www.sciencedirect.com/science/article/pii/S0028390825003120?via%3Dihub

Preterm functional outcomes are reflected in early postnatal proteome changes

Magdalena Zasada, Maciej Suski, Natalia Łapińska, Weronika Pogoda, Aleksandra Kowalik, Marta Olszewska & Przemko Kwinta

Pediatric Research (2025), Published: 17 July 2025: https://www.nature.com/articles/s41390-025-04227-2

Quantitative proteomics in rat saliva stimulated with pilocarpine and isoprenaline

Marcin Pasternak, Weronika Pogoda, Piotr Ceranowicz, Jakub Cieszkowski, Józef Madej, Rafał Olszanecki, Maciej Suski

Integrated Profiling Identifies Long‑Term Molecular Consequences of Prenatal Dexamethasone Treatment in the Rat Brain—Potential Triggers of Depressive Phenotype and Cognitive Impairment

Magdalena Kukla-Bartoszek, Marcin Piechota, Maciej Suski, Jacek Hajto, Małgorzata Borczyk, Agnieszka Basta-Kaim & Katarzyna Głombik

Molecular Neurobiology, November (2024):  https://doi.org/10.1007/s12035-024-04586-7

Mitochondria-targeted hydrogen sulfide donor reduces atherogenesis by changing macrophage phenotypes and increasing UCP1 expression in vascular smooth muscle cells

Aneta Stachowicz, Anna Wiśniewska, Klaudia Czepiel, Bartosz Pomierny, Alicja Skórkowska, Beata Kuśnierz-Cabala, Marcin Surmiak, Katarzyna Kuś, Mark E. Wood, Roberta Torregrossa, Matthew Whiteman, Rafał Olszanecki

Biomedicine & Pharmacotherapy, Volume 180, November (2024), 117527: https://doi.org/10.1016/j.biopha.2024.117527

Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathways

Aneta Stachowicz, Klaudia Czepiel, Anna Wiśniewska, Kamila Stachyra, Magdalena Ulatowska-Białas, Beata Kuśnierz-Cabala, Marcin Surmiak, Grzegorz Majka, Katarzyna Kuś, Mark E. Wood, Roberta Torregrossa, Matthew Whiteman, Rafał Olszanecki

Pharmacological Research, Volume 209, November (2024), 107428: https://doi.org/10.1016/j.phrs.2024.107428

Alterations in plasma proteome during acute COVID-19 and recovery

Maciej Suski, Agnieszka Olszanecka, Aneta Stachowicz, Anna Kiepura, Michał Terlecki, Józef Madej, Marek Rajzer, Rafał Olszanecki

Molecular Medicine; Volume 30, article number 131, (2024) https://link.springer.com/article/10.1186/s10020-024-00898-5

Physiological healing of chronic gastric ulcer is not impaired by the hydrogen sulphide (H2S)-releasing derivative of acetylsalicylic acid (ATB-340): functional and proteomic approaches

Edyta Korbut, Maciej Suski, Zbigniew Śliwowski, Dominik Bakalarz, Urszula Głowacka, Dagmara Wójcik-Grzybek, Grzegorz Ginter, Kinga Krukowska, Tomasz Brzozowski, Marcin Magierowski, John L. Wallace, Katarzyna Magierowska

Inflammopharmacology; Volume 32, pages 2049–2060, (2024) https://doi.org/10.1007/s10787-024-01458-3